AQST | Aquestive Therapeutics
Quick infos Headquarters: Warren Township, New Jersey, United States Trade prices Volume: Market Cap: 113.26M Prev closed: Open: 2.92 High: 2.94 Low: 2.75 52 week low: 2.02 52 week high: 6.4 Dividends: No Dividends Next ER: March 8, 2022 After Market Closes
Company Profile Aquestive Therapeutics is a specialty pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients.
Earnings History Date EPS / Forecast Revenue / Forecast May 11, 2022 March 8, 2022 -1.85 / -0.46650.83M / 9.36MBeat! November 2, 2021 -0.37 / -0.43813.29M / 11.01MBeat! August 3, 2021 -0.33 / -0.436715.35M / 9.48MBeat! May 4, 2021 -0.41 / -0.42511.12M / 8.97MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Mar 8, 2022 2.820 2.920 2.940
2.750
347.67K -4.08% Mar 7, 2022 2.940 2.900 2.990
2.849
232.66K 1.38% Mar 4, 2022 2.900 3.010 3.033
2.860
379.84K -4.61% Mar 3, 2022 3.040 3.050 3.190
2.950
395.09K 4.83% Mar 2, 2022 2.900 2.950 2.980
2.850
242.52K 0.69% Mar 1, 2022 2.880 2.860 3.040
2.820
428.91K 3.23% Feb 28, 2022 2.790 2.770 2.880
2.656
213.03K 0.36% Feb 25, 2022 2.780 2.590 2.867
2.570
566.44K 12.10% Feb 24, 2022 2.480 2.080 2.490
2.020
274.02K 8.77% Feb 23, 2022 2.280 2.330 2.400
2.260
213.17K -0.44% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2004 Employees:277 Parent Organization : MonoSol, LLC News
Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance finance.yahoo.com Dec 17, 2021 5:55 pm
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action AQST finance.yahoo.com Dec 17, 2021 5:00 pm
AQST ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. AQST finance.yahoo.com Dec 17, 2021 2:59 pm Aquestive Therapeutics EPS beats by $0.06, beats on revenue seekingalpha.com Nov 3, 2021 5:17 am
ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action - AQST finance.yahoo.com Dec 17, 2021 2:25 pm
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST) finance.yahoo.com Dec 17, 2021 1:00 pm
IMPORTANT APRIL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Dec 17, 2021 1:00 pm
APRIL 30 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Dec 17, 2021 12:30 pm
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors With LARGE LOSSES to Secure Counsel Before Important finance.yahoo.com Dec 17, 2021 12:00 pm
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Dec 17, 2021 11:33 am
MGI, AQST & VLDR Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm finance.yahoo.com Dec 17, 2021 11:00 am
MGI, AQST & VLDR Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm finance.yahoo.com Dec 17, 2021 11:00 am
MGI, AQST & VLDR Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm finance.yahoo.com Dec 17, 2021 11:00 am
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST) finance.yahoo.com Dec 17, 2021 11:00 am
AQST Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Aquestive Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 30, 2021 finance.yahoo.com Dec 17, 2021 11:00 am
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST) finance.yahoo.com Dec 17, 2021 11:00 am
MGI, AQST & VLDR Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm finance.yahoo.com Dec 17, 2021 10:00 am
AQST Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Aquestive Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 30, 2021 finance.yahoo.com Dec 17, 2021 10:00 am
AQST Final Deadline Today: Rosen, Trusted National Trial Counsel, Encourages Aquestive Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important April 30 Deadline in Securities Class Action - AQST finance.yahoo.com Dec 17, 2021 9:44 am
Aquestive Therapeutics to Report First Quarter 2021 Financial Results and Recent Business Highlights on May 4 and Host Conference Call on May 5 at 8:00 a.m. ET finance.yahoo.com Dec 17, 2021 9:19 am This company doesn't provide a dividend.
Talk about Aquestive Therapeutics below in comments section below. Do you think you'll buy? Do you already have active trades now?
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
